Literature DB >> 1870674

Malignant prolactinomas.

E A Popovic1, J R Vattuone, K H Siu, I Busmanis, M J Pullar, J Dowling.   

Abstract

Six cases of malignant prolactinoma have been reported; an additional two cases are presented here and the literature is reviewed. Diagnosis rests upon evidence of metastasis rather than histological criteria per se. Cases have arisen from known adenomas, particularly the invasive type. Bromocriptine is a useful palliative. The features and treatment of malignant prolactinoma are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 1870674     DOI: 10.1097/00006123-199107000-00023

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

Review 1.  Malignant pituitary tumours.

Authors:  G A Kaltsas; A B Grossman
Journal:  Pituitary       Date:  1998-04       Impact factor: 4.107

2.  Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma.

Authors:  M Fujikawa; K Okamura; K Sato; M Shiratsuchi; T Yao; T Mizokami; M Fujishima
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

3.  Pituitary carcinoma.

Authors:  M D Cusimano; P Ohori; A J Martinez; C Jungreis; D C Wright
Journal:  Skull Base Surg       Date:  1994

Review 4.  Pituitary carcinoma with intraspinal metastasis: report of two cases and review of the literature.

Authors:  Yin Qian Wang; Tao Fan; Xin Gang Zhao; Cong Liang; Xue Ling Qi; Jian Yi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 5.  Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.

Authors:  M Sironi; G Cenacchi; L Cozzi; G Tonnarelli; M Iacobellis; D Treré; A Assi
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

6.  Invasive pituitary adenomas: significance of proliferation parameters.

Authors:  A P Amar; D R Hinton; M D Krieger; M H Weiss
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

7.  Dopaminergic resistance in a case of invasive macroprolactinoma.

Authors:  D Schwarzstein; A García-Patterson; G Giménez; J Calaf; M Puig-Domingo; A Caixàs; X Matías-Guiu; S M Webb
Journal:  J Endocrinol Invest       Date:  1993-06       Impact factor: 4.256

8.  Prolactin secreting pituitary carcinoma.

Authors:  T Petterson; I A MacFarlane; J M MacKenzie; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

9.  Radiotherapy for pituitary adenomas: long-term outcome and complications.

Authors:  Chai Hong Rim; Dae Sik Yang; Young Je Park; Won Sup Yoon; Jung Ae Lee; Chul Yong Kim
Journal:  Radiat Oncol J       Date:  2011-09-30

10.  Pituitary Carcinomas.

Authors:  Wolfgang Saeger; Dorothee Lubke
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.